# Efficacy of OnabotulinumtoxinA in Migraine

> **NCT04578782** · PHASE2 · COMPLETED · sponsor: **IRCCS National Neurological Institute "C. Mondino" Foundation** · enrollment: 32 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** OnabotulinumtoxinA

## Key facts

- **NCT ID:** NCT04578782
- **Lead sponsor:** IRCCS National Neurological Institute "C. Mondino" Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-13
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-05-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04578782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04578782, "Efficacy of OnabotulinumtoxinA in Migraine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04578782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*